Small Business Resources, Business Advice and Forms from AllBusiness.com

Italy targets: knowledge-based companies for growth: expanding companies in industries such as...

By Thuermer, Karen E.
Publication: Expansion Management
Date: Friday, September 1 2006

FROM FERRARI SPORTS CARS TO LILLY Espresso coffee, Italy is associated with the finer things in life. After all, this is the country that brought the world the Renaissance.

Today, Italy is embarking on another Renaissance of sorts, this time fueled by high technology and the sciences.

The Italian government has targeted the life sciences, information and communications technologies (ICT), and nanotechnology among its top sectors for expansion projects. The nation has a tradition of innovation and an entrepreneurial spirit.

Bologna, in the Emilia R

In addition, make sure to read these premium articles also available with your free trial:

T T T
art_print Printart_email Email 16x16-digg-guy  Digg It delicious-small  del.icio.us

Related Resources

Free AllBusiness Articles

  • Sorting out the vagrancies of pharmaceutical R&D.
    • Cautious instrument spending by the pharmaceutical and biotech industries has been a lingering trend over the last two years. This trend is now regularly cited in the earnings announcements, conference calls and press conferences of life science instrument companies. Along with the general economic climate and delays in government funding, ......
  • Industry Execs Start New Ventures.
    • As the life sciences and drug discovery markets get ever more competitive, two well-known executives in the analytical instrument and life sciences industry have created new companies designed specifically for this fast-moving arena. Riccardo Pigliucci and Noubar B. Afeyan, both of whom are known for their leadership in large companies ......
  • Drug Discovery Technology 2001: An Increasingly Important Venue.
    • Drug discovery is a long, multi-step and extremely complex process. Technological advances have made drug discovery both faster and smarter, and new technologies are posed to continue to advance all stages of the drug discovery process. As the technologies for drug discovery continue to appear and evolve, the issues surrounding ......
  • Technology Transfer in BioBanking: Credits, Debits, and Population Health Futures
    • Bioinformatics, the integration of information technology and biotechnology, is the primary means to make medical sense out of the map of the human genome,1 and bioinformatics capabilities continue to expand exponentially.2 Consequently, the demand for access to human biological samples and medical information has never been greater.3 This demand is ......
  • The challenges of data management in biotech
    • HEADNOTE Storage Networking HEADNOTE Booming life sciences research has IT resources bursting at the seams IMAGE PHOTOGRAPH 3 Pharmaceutical companies typically spend over $200 million and around 12 years to hypothesize, develop, and seek FDA approval for a new drug. Pharmaceuticals and other life sciences companies are desperately seeking faster ......
  • Entelos Trading Update.
    • FOSTER CITY, Calif. -- Entelos, Inc. (LSE:ENTL), a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announces today that because two of its customers have reprioritized their internal clinical programs, there will be a decrease in the expected revenue ......
  • This month, a House-Senate conference committee agreed on a final version of the fiscal 2006 Interior and Environment appropriations bill.
    • Environment: This month, a House-Senate conference committee agreed on a final version of the fiscal 2006 Interior and Environment appropriations bill. It will increase the Environmental Protection Agency's (EPA) R&D budget by 1.2% to $579 million. However, the EPA's overall budget will decrease 4.1% to $7.7 billion. EPA Science and ......

Blogs

  • As Federal R&D Funding Fades, State Efforts Ramp Up
    • The federal government is leaving the nation and small businesses another sad legacy that may be felt for years to come: Spending on research and development has been declining for most of President Bush's term in office.
  • More on Nano-Investing, as Promised
    • To get a pulse on what is going on in the diverse, often misunderstood "nano" market, I turned to my good friend Ed Moran, of the Technology, Media & Telecommunications Group at Deloitte Services LLP. Ed has been following the "nano" industry for the past five or six years, working ......
  • All Bloggers
Related Topics
Tools

Sponsored Links

Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.